Nymox Announces Conference Call to Review Corporate Developments
HASBROUCK HEIGHTS, N.J., May 30, 2012 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) announced today that it will host a teleconference call on June 13, 2012 at 4:30 pm Eastern time, to review corporate developments, updates and discussion.
The toll-free dial-in number to participate on this call is (888) 895-5271 (U.S. and Canada), confirmation code 32584000. The toll-free dial-in number for International is (847) 619-6547, confirmation code 32584000.
During the call Dr. Paul Averback, Nymox's President and CEO will provide an overview of business highlights, and a question and answer session will take place.
More information about Nymox is available at www.nymox.com, email: email@example.com, or 800-936-9669.
This press release contains certain "forward-looking statements" as defined in the United States Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management's current expectations. Development of drug products involves substantial risks and actual results may differ materially from expectations. Such factors are detailed from time to time in Nymox's filings with the United States Securities and Exchange Commission and other regulatory authorities.
CONTACT: For Further Information Contact: Roy Wolvin Nymox Pharmaceutical Corporation 1-800-93NYMOX www.nymox.com
(C) Copyright 2012 GlobeNewswire, Inc. All rights reserved.